Paper2013328
Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.
Murata M and 8 others. FEBS Lett, 1991. Cited by 240 papers, by iCite.
Cite this record
ConductScience Library. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. Papers, record 2013328. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2013328
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cathepsin B | Major topic |
| Cysteine Endopeptidases | Major topic |
| Dipeptides | Major topic |
| Endopeptidases | Major topic |
| Liver | Major topic |
| Animals | |
| Calpain | |
| Cathepsin H | |
| Cathepsin L | |
| Cathepsins | |
| In Vitro Techniques | |
| Leucine | |
| Rats |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 240 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42020353 | Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42020353 | PubMed |
| 40700403 | Neutral pH-Selective Inhibition of Cytosolic Cathepsin B: A Novel Drug Targeting Strategy for Traumatic Brain Injury and Alzheimer's Disease. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/40700403 | PubMed |
| 40394881 | Redirecting the Peptide Cleavage Causes Protease Inactivation. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/40394881 | PubMed |
| 38915559 | Preventing trogocytosis by cathepsin B inhibition augments CAR T cell function. | bioRxiv | 2025 | https://conductscience.org/library/papers/38915559 | PubMed |
| 38757505 | Nature-Inspired Gallinamides Are Potent Antischistosomal Agents: Inhibition of the Cathepsin B1 Protease Target and Binding Mode Analysis. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/38757505 | PubMed |
| 37459182 | Distinct Cleavage Properties of Cathepsin B Compared to Cysteine Cathepsins Enable the Design and Validation of a Specific Substrate for Cathepsin B over a Broad pH Range. | Biochemistry | 2023 | https://conductscience.org/library/papers/37459182 | PubMed |
| 37289648 | Radioactive and Fluorescent Dual Modality Cysteine Cathepsin B Activity-Based Probe for Cancer Theranostics. | Mol Pharm | 2023 | https://conductscience.org/library/papers/37289648 | PubMed |
| 37128508 | Roles of host proteases in the entry of SARS-CoV-2. | Anim Dis | 2023 | https://conductscience.org/library/papers/37128508 | PubMed |
| 36685301 | Cathepsin-B inhibitor CA-074 attenuates retinopathy and optic neuritis in experimental autoimmune encephalomyelitis induced in SJL/J mice. | Saudi Pharm J | 2023 | https://conductscience.org/library/papers/36685301 | PubMed |
| 36574159 | Elucidation of chemical profiles and molecular targets of Mondia whitei leave fractions bioactive as novel therapeutics: an in vitro and in silico assay. | J Genet Eng Biotechnol | 2022 | https://conductscience.org/library/papers/36574159 | PubMed |
| 36467578 | Structure determinants defining the specificity of papain-like cysteine proteases. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/36467578 | PubMed |
| 36286438 | Caspase-1 and Cathepsin B Inhibitors from Marine Invertebrates, Aiming at a Reduction in Neuroinflammation. | Mar Drugs | 2022 | https://conductscience.org/library/papers/36286438 | PubMed |
| 36144371 | Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection. | Microorganisms | 2022 | https://conductscience.org/library/papers/36144371 | PubMed |
| 35910167 | Discovery of pH-Selective Marine and Plant Natural Product Inhibitors of Cathepsin B Revealed by Screening at Acidic and Neutral pH Conditions. | ACS Omega | 2022 | https://conductscience.org/library/papers/35910167 | PubMed |
| 35710131 | Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders. | Pharmacol Rev | 2022 | https://conductscience.org/library/papers/35710131 | PubMed |
| 35446477 | Photoresponsive Small Molecule Inhibitors for the Remote Control of Enzyme Activity. | Chem Asian J | 2022 | https://conductscience.org/library/papers/35446477 | PubMed |
| 35181782 | Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity. | Hum Mol Genet | 2022 | https://conductscience.org/library/papers/35181782 | PubMed |
| 35119840 | Molecular Features of CA-074 pH-Dependent Inhibition of Cathepsin B. | Biochemistry | 2022 | https://conductscience.org/library/papers/35119840 | PubMed |
| 34416110 | Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions. | ACS Chem Biol | 2021 | https://conductscience.org/library/papers/34416110 | PubMed |
| 33510618 | The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes. | Front Mol Neurosci | 2020 | https://conductscience.org/library/papers/33510618 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTSB | 1508 | PubTator's text mining | https://conductscience.org/library/genes/1508 | NCBI Gene |
| CTSH | 1512 | PubTator's text mining | https://conductscience.org/library/genes/1512 | NCBI Gene |
| CTSL | 1514 | PubTator's text mining | https://conductscience.org/library/genes/1514 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2013328
GET https://conductscience.org/api/papers/v1/2013328/cited_by?page=2